Rösser Nina, Heuschmann Peter, Wersching Heike, Breitenstein Caterina, Knecht Stefan, Flöel Agnes
Department of Neurology, University of Münster, Münster, Germany.
Arch Phys Med Rehabil. 2008 Sep;89(9):1633-41. doi: 10.1016/j.apmr.2008.02.030.
To test the hypothesis that administration of dopamine precursor levodopa improves procedural motor learning (defined as the ability to acquire novel movement patterns gradually through practice) in patients with residual motor deficits in the chronic phase after stroke (> or =1 y after stroke).
A double-blind, placebo-controlled, randomized crossover design.
Neurology department in a German university.
Eighteen patients with chronic motor dysfunction because of stroke (13 men, 5 women; age range, 53-78 y; mean time poststroke +/- SD, 3.3+/-2.1 y).
Patients received 3 doses of levodopa (100mg of levodopa plus 25mg of carbidopa) or placebo before 1 session of procedural motor learning.
Procedural motor learning performed by using the paretic hand assessed by using a modified version of the serial reaction time task with a probabilistic sequence. The primary outcome measure was the difference in reaction times between random and sequential elements.
Levodopa significantly improved our primary outcome measure, procedural motor learning, compared with placebo (P<.05). Reaction times to random elements, analysis of error rates, psychophysical assessments, and performance in a simple motor task were comparable between conditions, indicating that better learning under levodopa was not caused by differences in response styles, arousal, mood, or motor reaction times but that levodopa modulated learning.
Our results show that levodopa may improve procedural motor learning in patients with chronic stroke, in line with our hypothesis. These findings suggest that this interventional strategy in combination with customary rehabilitative treatments could significantly improve the outcome of neurorehabilitation in the chronic stage after stroke. (Clinicaltrials.gov identifier NCT00126087.)
验证如下假设,即给予多巴胺前体左旋多巴可改善卒中后慢性期(卒中后≥1年)存在残余运动功能障碍患者的程序性运动学习能力(定义为通过练习逐渐获得新运动模式的能力)。
双盲、安慰剂对照、随机交叉设计。
德国一所大学的神经科。
18例因卒中导致慢性运动功能障碍的患者(13例男性,5例女性;年龄范围53 - 78岁;卒中后平均时间±标准差,3.3±2.1年)。
患者在进行1次程序性运动学习前接受3剂左旋多巴(100mg左旋多巴加25mg卡比多巴)或安慰剂。
使用患侧手进行程序性运动学习,通过采用概率序列的改良版序列反应时任务进行评估。主要观察指标是随机元素和序列元素之间反应时间的差异。
与安慰剂相比,左旋多巴显著改善了我们的主要观察指标——程序性运动学习(P<0.05)。随机元素的反应时间、错误率分析、心理物理学评估以及简单运动任务中的表现在不同条件下具有可比性,表明左旋多巴作用下更好的学习并非由反应方式、唤醒水平、情绪或运动反应时间的差异所致,而是左旋多巴调节了学习过程。
我们的结果表明,左旋多巴可能改善慢性卒中患者的程序性运动学习,符合我们的假设。这些发现提示,这种干预策略与常规康复治疗相结合可显著改善卒中后慢性期神经康复的效果。(Clinicaltrials.gov标识符NCT00126087。)